Evidence map›Paper›PMID 36176940›Full record

ReviewGlobal challenges (Hoboken, NJ)2022

Effective Separation of Cancer-Derived Exosomes in Biological Samples for Liquid Biopsy: Classic Strategies and Innovative Development.

Yujiao Xie, Xiawei Xu, Jie Lin, Yanping Xu, Jing Wang, Yong Ren, Aiguo Wu

Open access · goldAbstract readReview
In one paragraph

Review in Global challenges (Hoboken, NJ), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yujiao XieCixi Institute of Biomedical Engineering International Cooperation Base of Biomedical Materials Technology and Application Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering CAS Ningbo 315201 P. R. China.
Xiawei XuCixi Institute of Biomedical Engineering International Cooperation Base of Biomedical Materials Technology and Application Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering CAS Ningbo 315201 P. R. China.
Jie LinCixi Institute of Biomedical Engineering International Cooperation Base of Biomedical Materials Technology and Application Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering CAS Ningbo 315201 P. R. China.
Yanping XuCixi Institute of Biomedical Engineering International Cooperation Base of Biomedical Materials Technology and Application Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering CAS Ningbo 315201 P. R. China.
Jing WangDepartment of Electrical and Electronic Engineering University of Nottingham Ningbo China Ningbo 315100 China.
Yong RenResearch Group for Fluids and Thermal Engineering University of Nottingham Ningbo China Ningbo 315100 China.ORCID https://orcid.org/0000-0001-6865-5861
Aiguo WuCixi Institute of Biomedical Engineering International Cooperation Base of Biomedical Materials Technology and Application Chinese Academy of Science (CAS) Key Laboratory of Magnetic Materials and Devices and Zhejiang Engineering Research Center for Biomedical Materials Ningbo Institute of Materials Technology and Engineering CAS Ningbo 315201 P. R. China.
University of Nottingham Ningbo China · CNJi Hua Laboratory · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid biopsy has remarkably facilitated clinical diagnosis and surveillance of cancer via employing a non-invasive way to detect cancer-derived components, such as circulating tumor DNA and circulating tumor cells from biological fluid samples. The cancer-derived exosomes, which are nano-sized vesicles secreted by cancer cells have been investigated in liquid biopsy as their important roles in intracellular communication and disease development have been revealed. Given the challenges posed by the complicated humoral microenvironment, which contains a variety of different cells and macromolecular substances in addition to the exosomes, it has attracted a large amount of attention to effectively isolate exosomes from collected samples. In this review, the authors aim to analyze classic strategies for separation of cancer-derived exosomes, giving an extensive discussion of advantages and limitations of these methods. Furthermore, the innovative multi-strategy methods to realize efficient isolation of cancer-derived exosomes in practical applications are also presented. Additionally, the possible development trends of exosome separation in to the future is discussed in this review.

Indexed as

cancer‐derived exosomescancersliquid biopsiesseparation methods

Identifiers

PMID36176940
PMCPMC9463520
OpenAlexW4229441287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.